Skip to content
Choksi Laboratories logo

Choksi Laboratories

526546 BSE
Price unavailable

Choksi Laboratories (CHOKSILA) share price was ₹213.95 at the 28 Oct 2026 close; market capitalisation ₹149 Cr; P/E (TTM) 69.02; sector Healthcare Services. The share price rose 49.4% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 7.3% year on year to ₹12.06 Cr and net profit was ₹0.58 Cr, against ₹0.39 Cr a year earlier (compared with Jun 2025). Promoters held 31.48% of Choksi Laboratories in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 54/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹213.95 +68.90 +47.50% 1Y

Key Fundamentals

MicrocapHealthcare ServicesHealthcare
Market Cap
₹149 Cr
P/E (TTM)
69.02
EBITDA
₹12.30 Cr
Return on Equity
7.68%
Debt to Equity
1.34
Book Value
₹36.72
EPS (TTM)
₹3.10
52W High
₹227.90
52W Low
₹81.85

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Healthcare Services › Healthcare Service Provider

Dr Lal Pathlabs
₹1,905.4058.9231,982 Cr12.750.26%20.06%25.67%2,996 Cr545 Cr
Vijaya Diagnostic Centre
₹1,433.7078.6514,767 Cr15.430.14%18.07%19.22%879 Cr187 Cr
Metropolis Healthcare
₹548.7556.4011,380 Cr7.580.91%12.54%15.73%1,733 Cr203 Cr
Thyrocare Technologies
₹516.0546.578,214 Cr16.022.84%27.79%33.84%894 Cr176 Cr
Nephrocare Health Services
₹630.30150.436,338 Cr5.680.00%6.88%13.46%1,079 Cr85 Cr
Suraksha Diagnostic
₹319.1046.381,662 Cr6.790.16%12.90%14.70%329 Cr35 Cr
Krsnaa Diagnostics
₹494.8016.231,605 Cr1.640.40%10.35%10.64%862 Cr98 Cr
Choksi Laboratories (this company)
—69.02149 Cr5.830.00%7.68%12.31%48 Cr2 Cr
Median 8 companies₹548.7557.667,276 Cr7.190.21%12.72%15.22%887 Cr137 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

54 Average
Overall score

Data confidence 100/100

Category scores

Quality Good 64
Returns, margins, earnings quality 22% weight
Valuation Poor 34
Cheap vs sector & own history 24% weight
Growth Average 53
Sales & profit trajectory 9% weight
Financial Health Poor 26
Solvency, leverage, coverage 9% weight
Momentum Strong 99
Trend strength, vol-adjusted 12% weight
Ownership Good 56
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Weaknesses

5
  • Stock is trading at 5.03 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Promoter holding is low: 31.5%
  • Company has a low return on equity of 5.29% over last 3 years.

Technical Indicators

Oscillators

Bullish

Bearish
1
Neutral
5
Bullish
3

Overall

Bullish

Bearish
1
Neutral
5
Bullish
13

Moving Averages

Bullish

Bearish
0
Neutral
0
Bullish
10

Growth Rate

Revenue Growth
10.53% higher than 3Y

change over 1 year

Net Income Growth
33.33% higher than 3Y

change over 1 year

Cash Flow Change
-33.28%

change over 1 year

EBITDA Margin Change
-1.07%

change over 1 year Operating margin 27.2% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
8.88
7.95
8.79
11.12
10.74
9.26
10.38
11.4
11.24
11.12
10.82
12.82
12.06
Expenses
6.45
5.84
6.55
7.63
7.91
6.9
7.84
7.9
8.34
8.19
8.16
9.18
8.78
Operating Profit
2.43
2.11
2.24
3.49
2.83
2.36
2.54
3.5
2.9
2.93
2.66
3.64
3.28
OPM %
27.36%
26.54%
25.48%
31.38%
26.35%
25.49%
24.47%
30.7%
25.8%
26.35%
24.58%
28.39%
27.2%
Other Income
0
0.05
0
0.06
0.01
0.01
0.01
0.04
0
0.01
0.89
0.06
0.02
Interest
0.82
0.74
0.67
0.77
0.72
0.66
0.69
0.58
0.6
0.69
0.81
0.71
0.73
Depreciation
1.39
1.41
1.43
1.49
1.5
1.61
1.68
1.7
1.68
1.69
1.83
1.89
1.97
PBT
0.22
0.01
0.14
1.29
0.62
0.1
0.18
1.26
0.62
0.56
0.91
1.1
0.6
Tax %
-59.09%
0%
57.14%
46.51%
30.65%
20%
44.44%
26.98%
38.71%
57.14%
64.84%
6.36%
3.33%
Net Profit
0.36
0.01
0.06
0.68
0.42
0.08
0.11
0.92
0.39
0.24
0.31
1.03
0.58
EPS (₹)
0.52
0.01
0.09
0.98
0.6
0.11
0.16
1.32
0.56
0.34
0.45
1.48
0.83
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
24.45
25.1
28.63
30.4
33.74
28.16
25.69
30.04
34.44
36.7
41.78
46.01
46.82
Expenses
19.3
19.95
23.85
24.06
26.48
24.62
21.57
21.14
24.17
26.42
30.48
33.83
34.31
Operating Profit
5.15
5.15
4.78
6.34
7.26
3.54
4.12
8.9
10.27
10.28
11.3
12.18
12.51
OPM %
21.06%
20.52%
16.7%
20.86%
21.52%
12.57%
16.04%
29.63%
29.82%
28.01%
27.05%
26.47%
26.72%
Other Income
0.63
-0.05
0.86
0.35
0.25
-2.8
0.49
0.12
2.47
0.16
0.07
0.96
0.98
Interest
1.57
1.23
1.47
1.59
1.54
1.89
2.82
3.23
3.52
3.06
2.72
2.86
2.94
Depreciation
2.83
2.73
2.86
3.16
3.68
4.56
4.6
5.43
5.5
5.71
6.5
7.09
7.38
PBT
1.38
1.14
1.31
1.94
2.29
-5.71
-2.81
0.36
3.72
1.67
2.15
3.19
3.17
Tax %
36.23%
36.84%
32.06%
29.9%
30.13%
-32.05%
-7.12%
44.44%
13.71%
32.93%
29.3%
38.56%
—
Net Profit
0.88
0.72
0.89
1.35
1.6
-3.88
-2.61
0.21
3.21
1.11
1.52
1.96
2.16
EPS (₹)
1.26
1.03
1.28
1.94
2.3
-5.57
-3.75
0.3
4.61
1.59
2.18
2.81
3.1
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
6.97
6.97
6.97
6.97
6.97
6.97
6.97
6.97
6.97
6.97
6.97
6.97
Reserves
12.35
13.07
14.16
15.43
17.04
13.26
10.78
10.94
14.14
15.25
16.64
18.61
Borrowings
11.65
13.68
11.2
12.43
17.05
31.64
39.15
37.29
32.41
30.87
29.15
34.17
Other Liabilities
6.7
8.81
8.32
9.85
14.28
13.14
9.48
9.22
6.84
8.86
12.57
12.17
Total Liabilities
37.67
42.53
40.65
44.68
55.34
65.01
66.38
64.42
60.36
61.95
65.33
71.92
Fixed Assets
19.28
17.64
22.23
28.62
34.81
33.08
50.32
46.56
44.83
43.43
47.61
51.55
CWIP
2.73
8.99
4.28
0
3.23
13.06
0.5
1.67
0.31
2.99
0
0.4
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
15.66
15.9
14.14
16.06
17.3
18.87
15.56
16.19
15.22
15.53
17.72
19.97
Total Assets
37.67
42.53
40.65
44.68
55.34
65.01
66.38
64.42
60.36
61.95
65.33
71.92
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
2.3
0.01
6.57
6.25
6.91
2.87
5.9
7.88
8.25
11.55
11.78
7.86
Investing
-0.73
-0.01
-1.88
-4.92
-9.76
-13.76
-7.65
-2.71
-0.71
-6.65
-7.61
-7.07
Financing
-1.37
0
-4.89
-0.94
2.13
11.09
1.63
-5.07
-7.61
-4.58
-4.22
-1.2
Net Cash Flow
0.21
0
-0.2
0.39
-0.72
0.2
-0.12
0.1
-0.07
0.32
-0.04
-0.41
Free Cash Flow
1.4
0
4.18
1.3
-3.09
-11.18
-2.18
5.05
7.34
4.54
4.09
0.62
CFO/OP
53
0
124
124
137
111
68
75
73
117
122
69
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
126
125
112
119
95.09
90.6
116
125
113
103
98.46
117
Inventory Days
0
0
28.27
30.5
37.89
20.28
15.62
46.09
34.68
51.33
65.94
25.47
Days Payable
—
—
591
594
661
723
686
741
297
560
639
594
Cash Conversion Cycle
126
125
-451
-445
-528
-612
-554
-570
-150
-406
-475
-452
Working Capital Days
29.26
3.34
-23.71
-18.37
28.02
21.13
-49.73
-23.33
11.66
-49.13
-71.29
-35.14
ROCE %
7.94%
7.51%
7.33%
10.51%
10.09%
-1.48%
0%
6.4%
9.16%
8.87%
9.2%
9.44%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Choksi Laboratories insights

61 extracted metrics + investor summaries across FY11–FY27.

Shareholding Pattern

FIIs10.01%Public47.96%Others10.54%Promot.31.48%As ofSep 2026

Documents

Frequently Asked Questions about Choksi Laboratories

What does Choksi Laboratories Ltd do?
Incorporated in 1982, Choksi Laboratories Ltd provides contract testing and analytical services.[1]
Where is Choksi Laboratories Ltd (CHOKSILA) listed?
Choksi Laboratories Ltd trades under code 526546 on the BSE.
Which sector does Choksi Laboratories Ltd belong to?
Choksi Laboratories Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the market capitalisation of Choksi Laboratories Ltd?
Choksi Laboratories Ltd has a market capitalisation of ₹149.07 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Choksi Laboratories Ltd?
Choksi Laboratories Ltd trades at a PE ratio of 69.02 as of 28 Oct 2026, on earnings per share of ₹3.1, against a book value of ₹36.72 per share.
What is the 52-week high and low of Choksi Laboratories Ltd?
Over the last 52 weeks Choksi Laboratories Ltd has traded between ₹81.85 and ₹227.9 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Choksi Laboratories Ltd?
Choksi Laboratories Ltd reported a return on equity of 7.68%. Its debt-to-equity ratio is 1.34.

Company Information

Incorporated in 1982, Choksi Laboratories Ltd provides contract testing and analytical services.[1]

Website choksilab.com
Face Value ₹ 10
Shares Outstanding 69,67,384

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/526546.md for Choksi Laboratories Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month